Ima Wealth, Inc. Gilead Sciences, Inc. Transaction History

Ima Wealth, Inc.

$458 Million
Q3 2024

A detailed history of Ima Wealth, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ima Wealth, Inc. holds 104 shares of GILD stock, worth $9,410. This represents 0.0% of its overall portfolio holdings.

Number of Shares

104

Holding current value

$9,410

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $6,925 - $8,734	104 New	104 $8,000
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $9,780 - $11,158	-163 Reduced 81.91%	36 $2,000
Q4 2020 Feb 08, 2021	SELL	$56.65 - $64.55 $2.29 Million - $2.6 Million	-40,341 Reduced 99.51%	199 $12,000
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $101,595 - $127,738	-1,636 Reduced 3.88%	40,540 $2.56 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $947,654 - $1.1 Million	-13,100 Reduced 23.7%	42,176 $3.25 Million
Q1 2020 Apr 14, 2020	BUY	$62.63 - $80.22 $724,002 - $927,343	11,560 Added 26.44%	55,276 $4.13 Million
Q4 2019 Feb 24, 2020	BUY	$61.62 - $67.78 $829,158 - $912,047	13,456 Added 44.47%	43,716 $2.84 Million
Q3 2019 Oct 29, 2019	BUY	$62.51 - $69.0 $36,130 - $39,882	578 Added 1.95%	30,260 $1.92 Million
Q2 2019 Jul 19, 2019	BUY	$61.87 - $69.38 $60,880 - $68,269	984 Added 3.43%	29,682 $2.01 Million
Q1 2019 May 09, 2019	BUY	$62.53 - $70.05 $1.35 Million - $1.51 Million	21,577 Added 303.01%	28,698 $1.87 Million
Q4 2018 Jan 15, 2019	BUY	$60.54 - $79.0 $103,523 - $135,090	1,710 Added 31.6%	7,121 $445,000
Q3 2018 Oct 18, 2018	BUY	$71.28 - $78.92 $22,381 - $24,780	314 Added 6.16%	5,411 $418,000
Q2 2018 Aug 01, 2018	SELL	$64.88 - $75.68 $13,365 - $15,590	-206 Reduced 3.88%	5,097 $361,000
Q4 2017 Feb 05, 2018	BUY	$71.15 - $83.52 $377,308 - $442,906	5,303	5,303 $380,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.9 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.93 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.59 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.44 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ima Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ima Wealth, Inc. with notifications on news.

Account